Time-dependent sensitization of heart rate and blood pressure over multiple laboratory sessions in elderly individuals with chemical odor intolerance

Archives of Environmental Health

Volumn 52, Issue 1, 1997, Pages 6-17

  Bell, Iris R ^a,b   Schwartz, Gary E ^a   Bootzin, Richard R ^a   Wyatt, James K ^a,c  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b SOUTHERN ARIZONA VA HEALTH CARE SYSTEM   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BLOOD PRESSURE MONITORING; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ENVIRONMENTAL FACTOR; FEMALE; HEART RATE VARIABILITY; HUMAN; HUMAN EXPERIMENT; MALE; MULTIPLE CHEMICAL SENSITIVITY; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SMELLING DISORDER; SUPINE POSITION; SYSTOLIC BLOOD PRESSURE;

AGED; ALCOHOL DRINKING; BLOOD PRESSURE; CAFFEINE; DIET; FEMALE; HEART RATE; HUMANS; MALE; MULTIPLE CHEMICAL SENSITIVITY; ODORS; SENSORY THRESHOLDS; TIME FACTORS;

CACOSMIA;

EID: 0031041807     PISSN: 00039896     EISSN: None     Source Type: Journal    
DOI: 10.1080/00039899709603794     Document Type: Article

References (87)

1. Ashford NA, Miller CS. Chemical Exposures: Low Levels and High Stakes. New York: Van Nostrand Reinhold, 1991.
2. National Research Council. Multiple Chemical Sensitivities. Addendum to Biologic Markers in Immunotoxicology. Washington, DC: National Academy Press, 1992.
3. Rest KM. Advancing the understanding of multiple chemical sensitivity (MCS): overview and recommendations from an AOEC workshop. Toxicol Ind Health 1992; 8:1-13.
4. Nethercott JR, Davidoff LL, Curbow B, et al. Multiple chemical sensitivities syndrome: toward a working case definition. Arch Environ Health 1993; 48:19-26.
5. Cullen MR. The worker with multiple chemical sensitivities: an overview. Occup Med (State Art Rev) 1987; 2:655-62.
6. Sparks PJ, Daniel W, Black DW, et al. Multiple chemical sensitivity syndrome: a clinical perspective. I. Case definition, theories of pathogenesis, and research needs. J Occup Med 1994; 36:718-30.
7. Buchwald D, Garrity D. Comparison of patients with chronic fatigue syndrome, fibromyalgia, and multiple chemical sensitivities. Arch Intern Med 1994; 154:2049-53.
8. Bell IR, Peterson JM, Schwartz GE. Medical histories and psychological profiles of middle-aged women with and without selfreported illness from environmental chemicals. J Clin Psychiatry 1995; 56:151-60.
9. Fiedler N, Kipen HM, DeLuca J, et al. A controlled comparison of multiple chemical sensitivities and chronic fatigue syndrome. Psychosom Med 1996; 58:38-49.
10. Bell IR, Schwartz GE, Peterson JM, et al. Self-reported illness from chemical odors in young adults without clinical syndromes or occupational exposures. Arch Environ Health 1993; 48:6-13.
11. Bell IR, Schwartz GE, Peterson JM, et al. Possible time-dependent sensitization to xenobiotics: self-reported illness from chemical odors, foods, and opiate drugs in an older adult population. Arch Environ Health 1993; 48:315-27.
12. Bell IR, Schwartz GE, Amend D, et al. Sensitization to early life stress and response to chemical odors in older adults. Biol Psychiatry 1993; 35:857-63.
13. Bell IR, Miller CS, Schwartz GE, et al. Neuropsychiatric and somatic characteristics of young adults with and without selfreported chemical odor intolerance and chemical sensitivity. Arch Environ Health 1996; 51:9-21.
14. Bell IR, Schwartz GE, Peterson JM, et al. Symptom and personality profiles of young adults from a college student population with self-reported illness from foods and chemicals. J Am Coll Nutr 1993; 12:693-702.
15. Bell IR, Hardin E, Baldwin CM, et al. Increased limbic system symptomatology and sensitizability of young adults with chemical and noise sensitivities. Environ Res 1995; 70: 84-97.
16. Bell IR, Bootzin RR, Ritenbaugh C, et al. A polysomnographic study of sleep disturbance in community elderly with self-reported environmental chemical odor intolerance. Biol Psychiatry 1996; 40: 123-33.
17. Bell IR, Bootzin RR, Davis T, et al. Time-dependent sensitization of plasma beta-endorphin in community elderly with self-reported environmental chemical odor intolerance. Biol Psychiatry 1996; 40: 134-43.
18. Schwartz GE, Bell IR, Dikman ZV, et al. EEG responses to low level chemicals in normals and cacosmics. Toxicol Ind Health 1994; 10:633-43.
19. Bell IR, Schwartz GE, Peterson JM, et al. Quantitative EEG patterns during nose versus mouth inhalation of filtered room air in young adults with and without self-reported chemical odor intolerances. Submitted for publication.
20. Bell IR, Wyatt JK, Bootzin RR, et al. Slowed reaction time performance on a divided attention task in elderly with environmental chemical odor intolerance. Int J Neurosci 1996; 84:127-34.
21. Bell IR, Miller CS, Schwartz GE. An olfactory-limbic model of multiple chemical sensitivity syndrome: possible relationships to kindling and affective spectrum disorders. Biol Psychiatry 1992; 32:218-42.
22. Bell IR. Neuropsychiatric aspects of sensitivity to low level chemicals: a neural sensitization model. Toxicol Ind Health 1994; 10:277-312.
23. Bell IR. Clinically relevant EEC studies and psychophysiological findings: possible neural mechanisms for multiple chemical sensitivity. Toxicology 1996; 111:135-45.
24. Antelman SM. Time-dependent sensitization as the cornerstone for a new approach to pharmacotherapy: drugs as foreign/stressful stimuli. Drug Develop Res 1988; 14:1-30.
25. Antelman SM. Time-dependent sensitization in animals: a possible model of multiple chemical sensitivity in humans. Toxicol Ind Health 1994; 10:335-42.
26. Kalivas PW, Sorg BA, Hooks MS. The pharmacology and neural circuitry of sensitization to psychostimulants. Behav Pharmacol 1993; 4:315-34.
27. Hooks MS, Jones GH, Neuill DB, et al. Individual differences in amphetamine sensitization: dose-dependent effects. Pharmacol Biochem Behav 1992; 41:203-210.
28. Cervero F, Janig W. Visceral nociceptors: a new world order? Trends Neurosci 1992; 15:374-78.
29. Robinson TE, Becker JB, Presty SK. Long-term facilitation of amphetamine-induced rotational behavior and striatal dopamine release produced by a single exposure to amphetamine: sex differences. Brain Res 1982; 253:231-41.
30. Kosten TA, Miserendino MJD, Chi S, et al. Fischer and Lewis rat strains show differential cocaine effects in conditioned place preference and behavioral sensitization but not in locomotor activity or conditioned taste aversion. J Pharmacol Exp Ther 1994; 269:137-44.
31. Sills TL, Vaccarino FJ. Individual differences in sugar intake predict the locomotor response to acute and repeated amphetamine administration. Psychopharmacol 1994; 116:1-8.
32. Newlin DB, Thomson JB. Chronic tolerance and sensitization to alcohol in sons of alcoholics. Alcohol Clin Exp Res 1991; 15:399-405.
33. Sainsbury RS, Harris JL, Rowland GL. Sensitization and hippocampal type 2 theta in the rat. Physiol Behav 1987; 41:389-93.
34. Post RM, Weiss SRB, Pert A. The role of context and conditioning in behavioral sensitization to cocaine. Psychopharm Bull 1987; 23:425-29.
35. Stewart J, Badiani A. Tolerance and sensitization to the behavioral effects of drugs. Behav Pharmacol 1993; 4:289-312.
36. Burchfiel JL, Duffy FJ, Sim VM. Persistent effects of sarin and dieldrin upon the primate electroencephalogram. Toxicol Appl Pharmacol 1976; 35:365-79.
37. Edling C, Lindberg A, Ulfberg J. Occupational exposure to organic solvents as a cause of sleep apnoea. Br J Ind Med 1993; 50:276-79.
38. Morrow LA, Ryan CM, Hodgson MJ, et al. Alterations in cognitive and psychological functioning after organic solvent exposure. J Occup Med 1990; 32:444-50.
39. May KP, West SG, Baker MR, et al. Sleep apnea in male patients with the fibromyalgia syndrome. Am J Med 1993; 94:505-08.
40. Morrow LA, Kamis H, Hodgson MJ. Psychiatric symptomatology in persons with organic solvent exposure. J Consult Clin Psychol 1993; 61:171-74.
41. Black DW, Rathe A, Goldstein RB. Environmental illness. A controlled study of 26 subjects with "20th century disease." JAMA 1990; 264:3166-70.
42. Simon GE, Katon WJ, Sparks PJ. Allergic to life: psychological factors in environmental illness. Am J Psychiatry 1990; 147:901-06.
43. Simon GE, Daniell W, Stockbridge H, et al. Immunologic, psychological, and neuropsychological factors in multiple chemical sensitivity. A controlled study. Ann Int Med 1993; 19:97-103.
44. Doty RL, Deems DA, Frye RE, et al. Olfactory sensitivity, nasal resistance, and autonomic function in patients with multiple chemical sensitivities. Arch Otolaryngol Head Neck Surg 1988; 114:1422-27.
45. Antelman SM, Caggiula AR, Knopf S, et al. Amphetamine or haloperidol 2 weeks earlier antagonized the plasma corticosterone response to amphetamine: evidence for the stressful/foreign nature of drugs. Psychopharmacol 1992; 107:331-36.
46. Ewing JA. Detecting alcoholism: the CAGE questionnaire. JAMA 1984; 252:1905-07.
47. Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 1983; 39:37-49.
48. Taylor GJ, Bagby RM, Ryan DP, et al. Criterion validity of the Toronto Alexithymia Scale. Psychosom Med 1988; 50:500-09.
49. Block G, Woods M, Potosky A, et al. Validation of a self-administered diet history questionnaire using multiple diet records. J Clin Epidemiol 1990; 43:1327-35.
50. Henry JP, Haviland MG, Cummings MA, et al. Shared neuroendocrine patterns of post-traumatic stress disorder and alexithymia. Psychosom Med 1992; 54:407-15.
51. Schottenfeld RS, Cullen MR. Occupation-induced posttraumatic stress disorders. Am J Psychiatry 1985; 142:198-202.
52. Zioudrou C, Streaty RA, Klee WA. Opioid peptides derived from food proteins. J Biol Chem 1979; 254:2446-49.
53. Kalivas PW, Alesdatter JE. Involvement of N-methyl-D-aspartate receptor stimulation in the ventral tegmental area and amygdala in behavioral sensitization to cocaine. J Pharmacol Exp Ther 1993; 267:486-95.
54. Caggiula AR, Antelman SM, Aul E, et al. Prior stress attenuates the analgesic response but sensitizes the corticosterone and cortical dopamine responses to stress 10 days later. Psychopharmacol 1989; 99:233-37.
55. Antelman SM, Caggiula AR, Kocan D, et al. One experience with 'lower' or 'higher' intensity stressors, respectively, enhances or diminishes responsiveness to haloperidol weeks later: implications for understanding drug variability. Brain Res 1991; 566:276-83.
56. Antelman SM, Caggiula AR, Kiss S, et al. Neurochemical and physiological effects of cocaine oscillate with sequential drug treatment: possibly a major factor in drug variability. Neuropsy-chopharmacol 1995; 12:297-306.
57. Morrow LA, Steinhauer SR. Alterations in heart rate and pupillary response in persons with organic solvent exposure. Biol Psychiatry 1995; 37:721-30.
58. Fiedler N, Maccia C, Kipen H. Evaluation of chemically sensitive patients. J Occup Med 1992; 34:529-38.
59. Kjaergaard SK, Molhave L, Petersen OF. Human reactions to a mixture of indoor air volatile organic compounds. Atmos Environ 1991; 25A:1417-26.
60. Wang HW, Wysocki CJ, Gold GH. Induction of olfactory receptor sensitivity in mice. Science 1993; 260:998-1000.
61. Girgis M. Biochemical patterns in limbic system circuitry: bio-chemical-electrophysiological interactions displayed by chemi-trode techniques. In: Doane BK, Livingston KE (Eds). The Limbic System: Function Organization and Clinical Disorders. New York: Raven Press, 1986; pp 55-65.
62. Bokina AL, Eksler ND, Semenenko AD, et al. Investigation of the mechanism of action of atmospheric pollutants on the central nervous system and comparative evaluation of methods of study. Environ Health Perspect 1976; 13:37-42.
63. Gilbert ME. Repeated exposure to lindane leads to behavioral sensitization and facilitates electrical kindling. Neurotoxicol Ter-atol 1995; 17:131-41.
64. Groves PM, Thompson RF. Habituation: a dual-process theory. Psychol Rev 1970; 77:419-50.
65. Newlin DB, Pretorius MB. Prior exposures to the laboratory enhance the effect of alcohol. J Stud Alcohol 1991; 52:470-73.
66. Bell IR, Markley EJ, King DS, et al. Polysymptomatic syndromes and autonomic reactivity to nonfood stressors in individuals with self-reported adverse food reactions. J Am Coll Nutr 1993; 12:227-38.
67. Terr AL. Multiple chemical sensitivities (editorial). Ann Intern Med 1993; 119:163-64.
68. Brodsky CM. "Allergic to everything": a medical subculture. Psy-chosomatics 1983; 24:731-42.
69. Blass EM, Shide DJ, Weller A. Stress-reducing effects of ingesting milk, sugars, and fats. A developmental perspective. Ann NY Acad Sci 1989; 575:292-306.
70. Shide DJ, Blass EM. Opioid medication of odor preference induced by sugar and fat in 6-day-old rats. Physiol Behav 1991; 50:961-66.
71. Vežina P, Stewart J. Amphetamine administered to the ventral tegmental area but not to the nucleus accumbens sensitizes rats to systemic morphine: lack of conditioned effects. Brain Res 1990; 516:99-106.
72. Stewart J, Vežina P. Extinction procedures abolish conditioned stimulus control but spare sensitized responding to amphetamine. Behav Pharmacol 1991; 2:65-71.
73. Sorg BA, Willis JR, Nowatka TC, et al. A proposed animal neurosensitization model for multiple chemical sensitivity in studies with formalin. Toxicol 1996; 111: 135-45.
74. vonEuler C, Ogren SO, Eneroth P, et al. Persistent effects of 80 ppm toluene on dopamine-regulated locomotor activity and prolactin secretion in the male rat. Neurotoxicol 1994; 15:621-24.
75. Agnew HW, Webb WB, Williams RL. The first night effect: an EEG study of sleep. Psychophysiol 1966; 2:263-66.
76. Skeeog I, Lernfeld B, Landahl S, et al. A 15-year longitudinal study of blood pressure and dementia. Lancet 1996; 347:1141-45.
77. Launer LJ, Masaki K, Petrovitch H, et al. The association between midlife blood pressure levels and late-life cognitive function. JAMA 1995; 274:1846-51.
78. Bell IR, Amend D, Kaszniak AW, et al. Memory deficits, sensory impairment, and depression in the elderly. Lancet 1993; 341:62.
79. Alexopoulos CS, Meyers BS, Young RC. The course of geriatric depression with "reversible dementia": a controlled study. Am J Psychiatry 1993; 150:1693-99.
80. Bell IR, Edman JS, Selhub J, et al. Plasma homocysteine in vascular disease and in nonvascular dementia of depressed elderly people. Acta Psychiatrica Scand 1992; 86:386-90.
81. Bell IR, Baldwin CM, Russek LG, et al. Early life stress, negative paternal relationships, and chemical odor intolerance in middle-aged women: support for a neural sensitization model. Submitted for publication.
82. Baldwin CM, Bell IR, O'Rourke MK, et al. Personal and parental cardiopulmonary and diabetes [medical] risk ratios in a community sample with and without sensitivity to chemical stressors. San Diego, CA: Presentation at the 16th Annual Meeting of the Society of Behavioral Medicine; March 22-25, 1995.
83. Thyrum ET, Blumenthal JA, Madden DJ, et al. Family history of hypertension influences neurobehavioral function in hypertensive patients. Psychosom Med 1995; 57:496-500.
84. Ryan CM, Morrow LA, Hodgson M. Cacosmia and neurobehavioral dysfunction associated with occupational exposure to mixtures of organic solvents. Am J Psychiatry 1988; 145:1442-45.
85. Kukull WA, Larson EB, Bowen JD, et al. Solvent exposure as a risk factor for Alzheimer's disease: a case-control study. Am J Epidemiol 1995; 141:1059-71.
86. Fratiglioni L, Ahlbom A, Viitanen M. Risk factors for late-onset Alzheimer's disease: a population-based, case-control study. Ann Neurol 1993; 33:258-66.
87. French LR, Schuman LM, Moritimer JA. A case-control study of dementia of the Alzheimer type. Am J Epidemiol 1985; 121: 414-21.